Carbetapentane / Diphenhydramine / Phenylephrine Dosage
Applies to the following strengths: 30 mg-25 mg-10 mg; 30 mg-25 mg-7.5 mg/5 mL; 30 mg-25 mg-15 mg/5 mL
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Allergic Rhinitis
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 ml oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
1 to 2 tablets orally every 12 hours.
Usual Adult Dose for Cold Symptoms
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 ml oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
1 to 2 tablets orally every 12 hours.
Usual Adult Dose for Cough and Nasal Congestion
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 ml oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
1 to 2 tablets orally every 12 hours.
Usual Pediatric Dose for Allergic Rhinitis
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 mL oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release:
2 years to <6 years: 1.25 to 2.5 mL orally every 12 hours.
6 years to <12 years: 2.5 to 5 mL orally every 12 hours.
>=12 years: 5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
6 years to <12 years: 1/2 to 1 tablet orally every 12 hours.
>=12 years 1 to 2 tablets orally every 12 hours.
Usual Pediatric Dose for Cold Symptoms
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 mL oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release:
2 years to <6 years: 1.25 to 2.5 mL orally every 12 hours.
6 years to <12 years: 2.5 to 5 mL orally every 12 hours.
>=12 years: 5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
6 years to <12 years: 1/2 to 1 tablet orally every 12 hours.
>=12 years 1 to 2 tablets orally every 12 hours.
Usual Pediatric Dose for Cough and Nasal Congestion
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-7.5 mg/5 mL oral suspension, extended release:
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release:
2 years to <6 years: 1.25 to 2.5 mL orally every 12 hours.
6 years to <12 years: 2.5 to 5 mL orally every 12 hours.
>=12 years: 5 to 10 mL orally every 12 hours.
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-15 mg/5 ml oral suspension, extended release
carbetapentane/diphenhydramine/phenylephrine 30 mg-25 mg-10 mg oral tablet, extended release and chewable, extended release:
6 years to <12 years: 1/2 to 1 tablet orally every 12 hours.
>=12 years 1 to 2 tablets orally every 12 hours.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
More about carbetapentane / diphenhydramine / phenylephrine
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
